Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Cancer Res. 2012 May 2;72(13):3228–3237. doi: 10.1158/0008-5472.CAN-11-3747

Figure 7. Model of MEK inhibitor-induced feedback on ERBB receptor signaling pathways.

Figure 7

In untreated cells EGFR is phosphorylated at T669 by MEK/ERK, which inhibits activation of EGFR and ERBB3. In the presence of AZD6244, ERK is inhibited and T669 phosphorylation is blocked, increasing EGFR and ERBB3 tyrosine phosphorylation and up-regulating downstream signaling.